How to Collect a Patient Reported Outcome
Partner with Sanguine Bioscience to take advantage of our Direct-To-Patient model and in-home phlebotomy services.
Meet with one of our team members to discuss the project in detail and determine the survey/PRO requirements for your research.
- Custom Questions
- Validated Questions (SF-36, HAQ-DI)
- Longitudinal Administration
- Flare/Crisis Triggered Administration
Based on your study requirements, Sanguine will create a research protocol and informed consent form for submission and approval by the Institutional Review Board (IRB). PRO administration can be collected through a variety of verbal, physical, or electronic methods.
Upon study start, study participants are screened and consented for the survey/PRO and sample collection. Deidentified survey/PRO data is provided through a HIPAA-compliant researcher portal for real-time access.
Determine if more patient data is needed, if so, the patient can be contacted for a re-collection. Sanguine prides itself on a 95% patient retention rate when called upon for follow up visits.
The study is completed and the deidentified data is provided with your samples to be used as you see fit.